SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-23-021525
Filing Date
2023-02-14
Accepted
2023-02-14 16:04:55
Documents
1
Group Members
5AM CO-INVESTORS IV, L.P.5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS IV, LLCANDREW J. SCHWABDR. JOHN D. DIEKMANDR. KUSH PARMARDR. SCOTT M. ROCKLAGE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236172d1_sc13ga.htm SC 13G/A 250051
  Complete submission text file 0001104659-23-021525.txt   251856
Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures IV, L.P. (Filed by) CIK: 0001589315 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 23628703
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences